Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment

Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment

PurposeThis study aims to assess the prognostic value of inflammatory markers and clinical features in advanced or metastatic esophageal squamous cell carcinoma (ESCC) patients receiving anti-programmed death 1 (PD-1) treatment.MethodsBased on receiver operating characteristic curve (ROC) analysis,...

Full description

Bibliographic Details
Main Authors: Liangshan Da, Ziting Qu, Congjun Zhang, Yuanyuan Shen, Wei Huang, Yiyin Zhang, Kangsheng Gu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
esophageal squamous cell carcinoma
PD-1
inflammatory markers
prognosis
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1144875/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1144875/full

Similar Items